Joel Greenblatt's position in TG Therapeutics is currently worth $1.71 Million. That's 0.02% of their equity portfolio (713th largest holding). The first TG Therapeutics trade was made in Q3 2019. Since then Joel Greenblatt bought shares seven more times and sold shares on eight occasions. The stake costed the investor $598 Thousand, netting the investor a gain of 187% so far.